Literature DB >> 17280747

Seroprevalence of rubella among Jordanian women of childbearing age.

Najwa Jarour1, Wail A Hayajneh, Adel Balbeesi, Haidar Otoom, Abdullah Al-Shurman, Sa'ad Kharabsheh.   

Abstract

This study was conducted to assess immunity (seroprevalence) to rubella among Jordanian women of childbearing age. A multistage cluster sampling was used to recruit 1125 women of childbearing age (15-49 year) from the 12 Governorates of Jordan. Anti-rubella antibody titers were measured using enzyme-linked immunoassays. The overall immunity rate to rubella among women in childbearing age was 90.9% (CI: 88.8-92.9). However, the immunity rate was significantly lower in younger women aged 15-19 years (83%) compared to the whole cohort (P</=0.001) which means potential increased risk for congenital rubella syndrome (CRS). Immunity rates did not differ between regions and between urban and rural areas. Since the main priority is to decrease CRS among relatively susceptible cohorts, we recommend modifying the existing Expanded Program on Immunization with inclusion of a second dose of rubella vaccine at school entry (6 years of age) to decrease circulation of the virus among susceptible young females. We also recommend yearly catch-up school vaccination of young females entering the 10th grade for the next 10 years. Strengthening of rubella and CRS surveillance programs is also recommended in parallel with pre-marriage counseling regarding rubella and CRS for young females.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17280747     DOI: 10.1016/j.vaccine.2007.01.058

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Congenital rubella syndrome: the end is in sight.

Authors:  Scott R Lambert
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

2.  Sero-prevalence of rubella among pregnant women in Sub-Saharan Africa: a meta-analysis.

Authors:  Zemenu Yohannes Kassa; Siraj Hussen; Solomon Asnake
Journal:  Hum Vaccin Immunother       Date:  2020-03-20       Impact factor: 3.452

3.  The status of rubella IgG antibody titer between antenatal and postnatal among pregnant non-immune to rubella.

Authors:  Irfana Rasool; Ayesha Azad; Saeed Baradwan; Muhammad Salman Bashir; Dania Al-Jaroudi
Journal:  Hum Vaccin Immunother       Date:  2020-06-23       Impact factor: 3.452

4.  Rubella Immunity among Pregnant Women in Jeddah, Western Region of Saudi Arabia.

Authors:  Sharifa A Alsibiani
Journal:  Obstet Gynecol Int       Date:  2014-06-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.